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This work was  originally planned to  determine the presence of 
immune opsonins in  the  circulating blood  of  pneumonia patients 
after  crisis.  However,  while  the  work  was  under  way,  Neufeld 
and his associates  (I)  published their results on the same subject, 
in which they claim to have  found immune opsonins or bacterio- 
tropins in practically every case.  They also found that post-critical 
sera protected mice from many times the minimum lethal dose of 
virulent  pneumococci.  On  the  basis  of  this  work,  Neufeld  has 
undertaken to make a serum for the treatment of pneumonia.  Sub- 
sequently, Seligmann and Klopstock  (2),  and Boettcher  (3)  have 
been unable to confirm Neufeld's results. 
Since  Mennes'  (4)  first  work on the  subject,  phagocytosis has 
been considered an important means of defense in pneumonia; and 
yet so far no successful practical application has been made of this 
biological reaction in treatment.  Lamar  (5)  has  recently given a 
conservative review  of  the  subject  of  phagocytosis  and  pneumo- 
coccus immunity, which he concludes as follows :-- 
"With  our present knowledge, we  must view  the  power  of  an 
antipneumococcus serum to promote phagocytosis as  the  index of 
its  therapeutic  activity,  and  we  must  also  view  the  property  of 
spontaneous phagocytosis of  the  pneumococci, which  certain  ani- 
mals  exhibit,  as  the  determining cause  of  their  refractoriness  to 
infection.  The  only known exception to  this  is  the pigeon  .... 
These considerations do not exclude the probability that there may 
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be still other and undetermined factors concerned in the prevention 
of infection by the pneumococcus." 
Seligmann (6)  questions whether modern biological methods can 
explain  the crisis in pneumonia, and  Lamar has  turned his  atten- 
tion to the chemical side of the problem. 
However, in view of the importance which Neufeld attached to 
the presence of immune opsonins, and the inability of later workers 
to substantiate his findings, it seemed worth while to continue these 
studies.  Neufeld showed in his first communications the presence 
of what were apparently general pneumococcus immune opsonins, 
but later work proved that certain strains of pneumococci were not 
acted upon by serum possessing opsonic powers for other pneumo- 
cocci.  Such strains were called "serum-fast," but they were opson- 
ized  by  the  post-critical  sera  of  pneumonic patients  from  whom 
they were  derived.  In  other words,  a  certain marked  degree  of 
specificity  was  obtained  in  the  immune opsonins  of  post-critical 
pneumonic sera. 
EXl~EI~IMENa:AL PART. 
The  question of the speci~r~ty of opsonic immuni*y~:n  ' animals 
injected with  pneumococci and  the  relation  of  such fi51munity to 
the virulence of the strain used were studied in a  series of experi- 
ments.  It is unnecessary to give this work in detail, as the results 
all coincided.  With avirulent organisms it was possible to produce 
in the serum of injected rabbits immune opsonins for the homolo- 
gous  organisms,  but  none  for  heterologous  strains.  In  all  test- 
tube  reactions,  Neufeld's  technique,  followed  precisely,  was  em- 
ployed, as he has frequently criticized other workers on the ground 
that they varied the technique.  In addition, however, to  the test- 
tube experiments, the reaction was studied in the peritoneal cavity 
of rabbits and guinea pigs immunized to avirulent pneumococci by 
introducing virulent organisms and removing the peritoneal exudate 
by glass pipettes at  different intervals.  As this method of testing 
for immune bodies may interfere with the demonstration of a pro- 
tective  immunity,  these  experiments  were  ahvays  performed  in 
duplicate.  With each attempt to demonstrate phagocytic immunity 
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was made without removing peritoneal fluid.  In spite of the fact 
that the animals withstood large doses of the avirulent culture, no 
phagocytosis  of  the  virulent  pneumococci  could  be  detected  in 
the peritoneal  cavity,  nor were  the  animals  rendered  resistant  to 
virulent  cultures.  One  of  these  experiments is  given in  the  fol- 
lowing protocol : 
January  23,  I9-rI.--Guinea pigs  I-IO and 2-1o.  Have been immunized since 
December 29,  I9IO, with increasing doses  of avirulent pneumococci.  Last injec- 
tion January 18, 1911. 
January  23,  z9zz.--Guinea pig I-IO.  Received I  c.e. of virulent pneumococci 
intraperitoneally.  Peritoneal  fluid  removed  every  2  hours  showed  no  phago- 
cytosis.  Pneumococci increased in number.  Death in 36 hours. 
Guinea pig 2-1o.  Same dose.  No withdrawal of fluid' from peritoneal cavity. 
Death in 20 hours. 
Guinea pig X  (normal control).  Received intraperitoneal injection of o.5 c.c. 
of  the  same culture.  Death in 6o hours. 
Perhaps  the most interesting results were obtained with  organ- 
isms of a  moderate degree of virulence.  Here the technical diffi- 
culties of estimating immune opsonins on the basis of spontaneous 
phagocytosis in  salt  solution were more easily  overcome, and  the 
attempts, atj,immunizing were  much  simpler than  with  extremely 
virulent lmeunlococci.  In this series, carried out in a parallel man- 
ner, a high degree of opsonic immunity for the homologous organ- 
ism was produced.  Likewise, to  a  certain degree, phagocytic im- 
munity could be  shown to  exist  for virulent strains.  With  some 
strains  of  pneumococci which  showed  slight  spontaneous  phago- 
cytosis and  which were  only moderately virulent  for  rabbits,  the 
ability to  produce opsonins against virulent strains  and to  protect 
from  injections  of  such  strains  was  in  marked  contrast  to  the 
inability  of  avirulent  organisms  to  produce  immunity  toward 
heterologous strains. 
With very virulent organisms, there was some difficulty in raising 
the animals to a  sufficiently high grade of immunity to  withstand 
large  doses,  and  in  none of  them could we  demonstrate immune 
opsonins either toward  the homologous virulent  strain  or toward 
heterologous avirulent or moderately virulent ones.  Boettcher was 
likewise unable to produce phagocytic immunity for  very virulent 
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opsonins  for  moderately  virulent  organisms.  He  also  claims  to 
have  protected  mice  against  moderately  virulent  organisms  by 
previous injection of avirulent pneumococci. 
These results emphasize strongly the fact that pneumococcic im- 
munity is,  to a  high degree, specific for the organism used in  im- 
munization,  and  further  that  the  reaction  of  the  injected  animal 
depends to  a  great extent on the virulence of the organism.  My 
results with certain moderately virulent organisms indicate the pos- 
sibility of producing in  larger  animals  a  more general  immunity. 
Rosenow's  (7)  studies on the  increased  production of  antibodies 
by autolyzed and washed virulent pneumococci, as compared to the 
difficulty of  immunizing with the whole culture, may bear  a  close 
relation to  the point under discussion, since,  as Rosenow  (8)  has 
previously  shown,  virulent  non-phagocytable  pneumococci  after 
autolysis become avirulent and phagocytable. 
In the study of post-critical pneumonic sera,  Neufeld's technique 
was followed.  The sera were taken from twenty different patients, 
two to four days after crisis or lysis, and heated for twenty minutes 
at  54 °  C.  The pneumococci obtained either  from the sputum or 
blood of pneumonic patients were very virulent, were fatal in doses 
of  o.oooooi  cubic  centimeters  to  mice,  and  showed  no  spon- 
taneous phagocytosis.  They were grown in 5 per cent. beef serum 
bouillon.  The leucocytes were obtained from the peritoneal cavity 
of guinea pigs following aleuronat injection.  Incubation at 37 °  C. 
was  usually  for  one  and  a  half  hours,  sometimes  for  two  and 
a  half hours.  These are the conditions laid down by  Nenfeld as 
necessary  for  the  successful  demonstration of  immune  opsonins. 
One other factor of importance was considered in each experiment; 
namely, the source of the pneumococcus.  If "serum-fast"  strains 
exist,  opsonizable only by the homologous serum, then each strain 
used  must  be  tested  against  its  homologous  serum.  This  was 
carefully  controlled  in  each  set  of  experiments by  using  several 
sera and at  least two organisms, including one strain  homologous 
to one serum.  A  protocol of a typical experiment follows. 
Our  results  were  surprisingly  constant.  With  the  virulent 
organisms  showing  no  spontaneous  phagocytosis,  we  were  never 
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All  Sera  Heated  to  54 °  C.  for  Twenty  Minutes.  Dilutions  I:~O,  I:Ioo,  I:5o0, 
I:Iooo.  Incubation  at 37 °  C. /or One and a Half Hours. 
Pl,fient. 
A 
B 
C 
D 
E 
Pneumococcus. 
1  ! 
No phag0cytosis  C 
"  No phagocyt0sis  C 
No phagocytosis  C 
No phagocytosis  C 
No phagocytosis  C 
Result. 
No phagocytosis 
No phagocytosis 
No phagocytosis 
No phagocytosis 
No phagocytosis 
Pneumococcus B  is from the sputum of Patient B.  Pneumococcus C  is  from 
the sputum of  Patient  C. 
monic  patients.  This  general  result  includes  also  those  cases  in 
which sera  were tested against homologous organisms. 
In addition to  the  experiments with highly virulent  organisms, 
identical  experiments  were  performed  with  pnenmococci showing 
various degrees of spontaneous phagocytosis.  In work of this sort, 
it  is  hard  to  overcome  technical  difficulties  sufficiently  to  yield 
unbiassed  and  absolute  readings.  Great  care  must  be  taken  in 
striking a balance between the phagocytability of the organism and 
the time of incubation; there is danger of the "salt control" show- 
ing too much phagocytosis, and of the attempt to overcome this by 
shortening the time of incubation, in which case the  serum is  not 
permitted to opsonize the pneumococci. 
The plan of Lamar  (9)  to sensitize the pneumococci by the sera 
for  an  hour  before  adding  the  leucocytes was  followed  in  many 
experiments, and at times made the results less difficult to interpret. 
But  even  with  this  technique,  most  oJ[  the  work  with  organisms 
showing spontaneous phagocytosis could not be accepted by an im- 
partial  observer,  and  only  a  few  experiments  gave results  suffi- 
ciently sharply defined to permit of conclusions.  With  five  sera, 
two  of which  had been tested  against the more virulent pneumo- 
cocci with negative results, we were able definitely to show immune 
opsonins at a  dilution of I : 300.  One case of pneumococcus endo- 
carditis receiving autogenous vaccines showed immune opsonins in a 
dilution of I : 15oo, but to the homologous organism only.  It is in- 
teresting to  compare this  with my other results and with those of 
Meakins  (Io)  on  streptococcus  endocarditis.  It  may  also  be  of 
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pneumococcus immunity to state that this patient died although her 
opsonins described an upward course. 
Neufeld found that the post-critical sera which showed opsonins 
in test-robe experiments also protected mice from many times the 
minimum lethal dose of virulent organisms; and in my series,  sera 
of eight different patients were tested in an identical manner.  Two 
hours  after  intraperitoneal  injection  of  o.2  cubic  centimeters  of 
post-critical  sera,  various  multiples  of  the  minimum lethal  dose 
(o.oooom  cubic  centimeters)  of  virulent  pneumococci  were  in- 
jected.  As might be expected from the test-tube experiments, these 
animal  inoculations  were  completely  negative.  Boettcher  also 
failed  to  find any protective action of post-critical sera  for  mice. 
It is probable that with less virulent cultures the same results would 
be  obtained  in  animal  experiments  as  were  shown  in  the  test 
tube; but an insufficient supply of mice prevented a  more extensive 
investigation. 
SUMMARY. 
These  results  seem  definitely to  show,  through  animal  experi- 
ments, that phagocytic immunity is to a high degree specific for the 
organism used  in  immunization, and that  the  amount  of  opsonin 
produced in the process depends to a  great extent on the virulence 
of the organism.  The negative results obtained with post'-critical 
sera do not mean that opsonins may not be present  (our five posi- 
tive cases indicate their presence), but they emphasize strongly the 
fact that they are not formed to any great extent.  Therefore this 
study adds  further support to  the view that although opsonic im- 
munity is produced in pneumonia, it  is not the only means of de- 
fense  possessed by  the  body,  and  by  itself  it  cannot  explain  the 
crisis. 
In conclusion, I  wish to acknowledge my indebtedness to Dr.  J. 
W.  Jobling  for  many  helpful  criticisms  and  suggestions  in  the 
course of this work, and to Drs. Johnson, Goodkind, and Edwards 
for the privilege of studying the cases in the medical wards of the 
hospital. 
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